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1. Introduction and aims 
 
Steroid derivatives are applied for clinical purposes worldwide. The medical 
applications of cardenolides and bufadienolides are associated with high risk, due to 
their exceptional toxicity and the small difference between the therapeutic and toxic 
doses. In the past few years, increasing attention has been paid to the synthesis of 
cardenolide analogues containing a heterocyclic ring at C-17, which are expected to 
have better therapeutic indices. Besides cardiotonic activity, a large number of exo-
heterocyclic steroids at position C-17 display high inhibitory activity towards 17α-
hydroxylase-C17,20-lyase (P45017α) and 5α-reductase. Androgens are known to play a 
critical role in the development and progression of prostatic diseases such as benign 
prostatic hyperplasia and prostate carcinoma. P45017α and 5α-reductase are key 
enzymes in the androgen biosynthesis pathway. Inhibition of these pivotal enzymes 
in the androgen synthesis cascade would diminish the circulating androgens and is a 
useful approach for the development of therapeutic agents for the treatment of 
prostatic diseases and other androgen-dependent diseases.  
In view of the available literature knowledge, we set out to synthetize exo-
heterocyclic steroids containing N and O, as novel presumed inhibitors of P45017α 
and/or 5α-reductase. The inhibitory effects of these compounds were investigated 
with an in vitro radioincubation technique for both P45017α and 5α-reductase. 
 
2. Experimental methods 
 
Reactions were monitored on the mmol scale, by thin-layer chromatography. The 
crude products were purified by flash chromatography. The structures of the 
compounds obtained were determined via the 1H and 13C NMR (including J-MOD, 
NOE, COSY, HMBC and HSQC) spectra, EI- and DCI-MS techniques and elemental 
analysis. 
 
 
 
2 
3.  Scientific results * 
 
3.1. Preparation of the α,β- and α,γ-diol systems on the side-chain of the sterane 
skeleton from 3β-acetoxypregn-5-en-20-one (38) as starting material was 
achieved by elongation of the side-chain of 38, by means of oxidation (66) and 
CLAISEN condensation (69), followed by reduction with KBH4 to the triols (67, 
70) (Scheme 1). 
 
3.2. For selective acetylation of the 3β-OH group, the cyclic acetonides of the 
mixture (71, 72) should first be prepared (73, 74). Under acidic conditions, the 
cyclic ketals produced were transformed to chromatographically separable 
mixtures of diols (75, 76 and 77, 78) (Scheme 1). 
 
3.3. APPEL reactions of the pure isomers 20S and 20R (75, 76) with CCl4 and PPh3 
produced 85 and 86. We found that the reaction was regioselective; only 21- 
(85) and 22-chloro derivatives (86) were formed (Scheme 1). 
 
3.4. To prepare the α,β- and α,γ-systems in the side-chain, nucleophilic exchange 
with NaN3 in dimethylformamide led to the required (20S)-3β-acetoxy-21- (87) 
and (20R)-3β-acetoxy-22-azidopregn-5-en-20-ol (88), as key compounds 
(Scheme 1).  
 
3.5. We found that the SCHMIDT reactions of the α,β- (87) and the α,γ-azidoalcohol 
(88) with appropriately substituted aromatic aldehydes (89a–i) activated by 
BF3.OEt2 as LEWIS acid catalyst proceeded cleanly to the corresponding 
dihydrooxazolines (103a–i) and dihydrooxazines (104a–i) in good yields 
(Scheme 1).  
* The numbering of the compounds accords with that in the Ph.D. Thesis 
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Scheme 1 
 
3.6. Deacetylation of the newly synthetized 3β-acetoxy compounds 103a–i and 
104a–h in methanol in the presence of NaOMe by the ZEMPLÉN method 
4 
resulted in the 3β-hydroxy derivatives (119a–i, 120a–h), without opening of 
the heterocyclic ring. OPPENAUER oxidation of the 3β-hydroxy-exo-heterocyclic 
steroids yielded the corresponding ∆4-3-ketosteroids (121a–i, 122a–g) in 
moderate yields (Scheme 2). 
 
3.7. A substituent effect was observed during the reaction. The speed of the ring 
closure depends on the electronic properties of the substituents on the 
aromatic aldehyde. In the case of aldehydes containing electron-withdrawing 
groups (89b–e, h, i) the ring closure was facilitated. In contrast, hydrogen (89a) 
or electron-donating groups (89f, g) on the aromatic ring retarded the SCHMIDT 
reaction (Scheme 2). 
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Scheme 2 
 
3.8. We established that the hydroxy group at position 20 was formed by 
controlled reduction of 3β,21-diacetoxypregn-5-en-20-one (66) at about pH 6.6, 
which gave a mixture of 20-hydroxy isomers (123 and 124) in a ratio of 9:1. 
These epimers could be separated by flash chromatography. On the other 
hand, the 22-acetoxy,20-hydroxy compound (125) was formed from 3β-
acetoxy-20,22-dihydroxypregn-5-ene (76) via selective esterification (Scheme 
3). 
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3.9.  We found that the azido group at position C-20 could be formed in two 
different ways. First, in a two-step reaction, p-tosyl ester formation from 123 
and 125 resulted in 126 and 127, which in subsequent reactions with NaN3 
were converted to the corresponding 20-azido compounds (128, 129). In the 
other method, 123 and 124 were transformed with HN3, PPh3 and diethyl 
diazenedicarboxylate into the corresponding azides (128, 129) in moderate 
yields. The MITSUNOBU reaction was accompanied by elimination to afford 
17(20)E-unsaturated compounds (130, 131) (Scheme 4).  
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3.10.  Compounds 132 and 133 for cyclization were obtained after deacetylation of 
128 and 129 (Scheme 8). We observed that in the 20-azido series, the α,β- and 
α,γ-azidoalcohols with differently substituted aromatic aldehydes (89a–i) 
furnished the corresponding dihydrooxazolinyl (134a–i) and dihydrooxazinyl 
(135a–h) steroids, similarly to the regioisomeric azidoalcohols (87, 88) (Scheme 
5). 
 
3.11. In the SCHMIDT reaction, it was proved that the ring closure depended on the 
electrophilic character of the substituent. Aromatic aldehydes containing 
electron-withdrawing groups (89b–e, h, i) took part in the ring-closure 
reaction more responsively, while aldehydes bearing electron-donating 
substituents (89f, g) or hydrogen (89a) were changed to cyclic products slowly. 
 
3.12. OPPENAUER oxidation of the 3β-hydroxy-exo-heterocyclic steroids (135a–h) 
yielded the corresponding ∆4-3-ketosteroids (136a–f). Acetylation of 134a–i 
and 135a–h gave the 3β-acetoxy compounds (137a–i, 138a–h) (Scheme 5). 
H
HO
H H
OH
H
H
HO
H H
H
N
O
R
BF3.OEt2
O
R
Ac2O
O
 89, 134−138  R
         a            H
         b            4-Cl
         c            3-Cl
         d            2-Cl
         e            4-Br
         f             4-OMe
         g            3,4,5-(tri)OMe
         h            4-NO2
          i            4-F
n nN3 H
H
AcO
H H
H
N
O
R
nH
H
H H
H
N
O
R
nH
H
AcO
H H
OAc
H
n N3
128  n=1
129  n=2
132  n=1
133  n=2
134a−i  (4'R), n=1
135a−h (4'S), n=2
137a−i  n=1
138a−h  n=2136a−f  n=2
OH-
O
89a-i
Al(OiPr)3
 
Scheme 5 
 
3.13. For the synthesis of the unsubstituted steroidal cyclic carbamates (143, 144), 
we used a different method. Under the conditions of the STAUDINGER reaction, 
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87 and 88 with Ph3P gave the 21- and 22-phosphimino compounds (139, 140), 
which were converted into the corresponding isocyanates (141, 142) with CO2. 
Their deacetylation in methanol in the presence of NaOMe by the ZEMPLÉN 
method furnished 145 and 146. OPPENAUER oxidation of the 3β-hydroxy-exo-
heterocyclic steroids (145, 146) yielded the corresponding ∆4-3-ketosteroids 
(147, 148) (Scheme 6). 
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Scheme 6 
 
3.14. We found that the 21-chloro derivative (85) was a suitable starting material for 
cyclization into steroid carbamates. 85 was reacted with phenyl isocyanate 
(149a) or substituted phenyl isocyanates (149b−f) in the presence of 
triethylamine to afford the desired 21-chloromethylpregn-5-ene-20-
arylurethanes (150a−f). During the alkaline methanolysis of 3β-acetoxy-21-
chloropregn-5-ene-20-N-phenylurethane (150a) or its 4-monosubstituted 
(150b–e) or 3,5-disubstituted (150f) phenyl derivatives, cyclization occurred, in 
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the course of which phenyl- (151a) and (N-substituted phenyl)-oxazolidinone 
derivatives (151b–f) were formed (Scheme 7). The cyclization took place with 
(N−-5) neighbouring group participation. 
 
3.15. The substituent effect was observed under the ring-closure reactions. The N-
phenylcarbamates bearing electron-withdrawing groups reacted rapidly, 
while the ring closure with electron-donating substituents took place slowly. 
 
3.16. OPPENAUER oxidation of the 3β-hydroxy-exo-heterocyclic steroids (152a–f) 
yielded the corresponding ∆4-3-ketosteroids (152a–f). Esterification of 152a–f 
by acetylation furnished the 3β-acetoxy compounds (153a–f) (Scheme 7).  
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Scheme 7 
 
3.17. The inhibitory effects (IC50) of these exo-heterocyclic compounds on rat 
testicular P45017α and 5α-reductase were investigated with an in vitro 
radioligand incubation technique. Both 3β-hydroxy- and ∆4-3-ketosteroids 
were tested.  
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3.18. Most of our newly synthetized exo-heterocyclic steroids displayed moderate or 
weak inhibitory action in the tests. However, there were some (5’S)-
dihydrooxazinyl derivatives whose IC50 values approximated that of the 
reference inhibitor (ketoconazole, 31). The most effective inhibitor in the 
investigation of the inhibitory effects of P45017α and 5αR2 was an 
unsubstituted oxazolidinone derivative (147).  
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